[Pharmacokinetic studies of cefotiam in late pregnancy].
Examining blood level values and urinary concentrations taken from pregnant women during the third trimester and nonpregnant female volunteers, the pharmacokinetic dates of cefotiam (a second generation's cephalosporin) have been evaluated. We used a computer program of an open two-compartment model for intravenous injection. We found an increase of some pharmacokinetic parameters (elimination half-life, distribution volume, clearance) during pregnancy. Because the serum levels were yet effective and nearly equal 6 hours after intravenous injection we state that it is not necessary to change the dosage and the application interval of cefotiam during pregnancy.
Voigt
R
R
Klinik für Frauenheilkunde und Geburtshilfe, Friedrich-Schiller-Universität Jena.
Schröder
S
S
Bierwisch
I
I
Michels
W
W
Spencker
F B
FB
D000328:Adult; D001437:Bacteriuria / Q000097:blood* / Q000188:drug therapy; D015310:Cefotiam / Q000008:administration & dosage / Q000493:pharmacokinetics*; D005260:Female; D006801:Humans; D008657:Metabolic Clearance Rate; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D011251:Pregnancy Complications, Infectious / Q000097:blood*
D015310:Cefotiam
Pharmakokinetische Untersuchungen von Cefotiam in der Spätschwangerschaft.